Fugen Li

4.2k total citations · 1 hit paper
69 papers, 2.0k citations indexed

About

Fugen Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Fugen Li has authored 69 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Fugen Li's work include Cancer Genomics and Diagnostics (9 papers), Colorectal Cancer Surgical Treatments (6 papers) and Pesticide Residue Analysis and Safety (6 papers). Fugen Li is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Colorectal Cancer Surgical Treatments (6 papers) and Pesticide Residue Analysis and Safety (6 papers). Fugen Li collaborates with scholars based in China, United States and United Kingdom. Fugen Li's co-authors include Gary D. Stormo, Henry W. Long, Ramesh A. Shivdasani, Stuart S. Levine, Myles Brown, J M Alexander, Alisha K. Holloway, Joseph A. Wamstad, Huiming Ding and Avanti Shrikumar and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Fugen Li

64 papers receiving 1.9k citations

Hit Papers

Dynamic and Coordinated Epigenetic Regulation of Developm... 2012 2026 2016 2021 2012 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fugen Li China 20 1.3k 441 423 346 240 69 2.0k
Larissa A. Pikor Canada 26 1.4k 1.0× 897 2.0× 405 1.0× 465 1.3× 200 0.8× 35 2.1k
Weidong Tian China 24 1.3k 1.0× 280 0.6× 267 0.6× 250 0.7× 187 0.8× 68 2.0k
Travis Clark United States 17 696 0.5× 391 0.9× 363 0.9× 252 0.7× 202 0.8× 39 1.6k
Gemma Armengol Spain 20 793 0.6× 326 0.7× 321 0.8× 274 0.8× 121 0.5× 41 1.5k
Yan Shi United States 23 1.1k 0.8× 558 1.3× 454 1.1× 410 1.2× 195 0.8× 88 2.1k
Florence Le Calvez‐Kelm France 25 1.3k 0.9× 820 1.9× 453 1.1× 783 2.3× 375 1.6× 68 2.4k
Reinhard Depping Germany 28 1.0k 0.8× 531 1.2× 165 0.4× 205 0.6× 230 1.0× 59 1.7k
Sheng Gao China 22 1.3k 0.9× 306 0.7× 126 0.3× 356 1.0× 150 0.6× 94 2.2k
Zheng Ge China 27 1.5k 1.1× 221 0.5× 141 0.3× 346 1.0× 131 0.5× 134 2.4k
Ruidong Li China 21 744 0.6× 462 1.0× 214 0.5× 188 0.5× 186 0.8× 95 1.5k

Countries citing papers authored by Fugen Li

Since Specialization
Citations

This map shows the geographic impact of Fugen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fugen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fugen Li more than expected).

Fields of papers citing papers by Fugen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fugen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fugen Li. The network helps show where Fugen Li may publish in the future.

Co-authorship network of co-authors of Fugen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Fugen Li. A scholar is included among the top collaborators of Fugen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fugen Li. Fugen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hong, Huangming, Mingzhi Zhang, Zhigang Peng, et al.. (2023). A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial of HH2853 in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphoma. Blood. 142(Supplement 1). 304–304. 2 indexed citations
3.
Chen, Li, Fugen Li, Zhentao Zhang, et al.. (2023). Residues and dietary risk assessment of fluazinam in root mustard after field experiments. Environmental Science and Pollution Research. 30(19). 56836–56843. 3 indexed citations
7.
Peng, Hao, Rong Huang, Kui Wang, et al.. (2020). Development and Validation of an RNA Sequencing Assay for Gene Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tumors. Journal of Molecular Diagnostics. 23(2). 223–233. 8 indexed citations
8.
Feng, Feiling, Huizhen Wang, Qingxiang Gao, et al.. (2020). Establishment and characterization of patient-derived primary cell lines as preclinical models for gallbladder carcinoma. Translational Cancer Research. 9(3). 1698–1710. 2 indexed citations
9.
Luo, Wenjun, et al.. (2020). A New Medial-to-Lateral Approach for Laparoscopic D3 Lymphadenectomy plus Complete Mesocolic Excision (D3 + CME) for Right-Sided Colon Cancer. Annals of Surgical Oncology. 28(6). 3256–3257. 4 indexed citations
10.
Luo, Wenjun, et al.. (2019). Surgical treatment of pyloric stenosis caused by glyphosate poisoning. Medicine. 98(30). e16590–e16590. 3 indexed citations
11.
Li, Fugen, Xiaozhou Xin, Zhiqing Peng, & Qinhuo Liu. (2019). Estimating daily evapotranspiration based on a model of evaporative fraction (EF) for mixed pixels. Hydrology and earth system sciences. 23(2). 949–969. 6 indexed citations
12.
Li, Fugen, et al.. (2018). Asymptotic Buckling Analysis of S-FGM Shallow Spherical Shells. Chinese Quarterly of Mechanics. 39(3). 494.
13.
Li, Fugen, Xiaozhou Xin, Zhiqing Peng, & Qinhuo Liu. (2018). Estimating Daily Evapotranspiration Based on a Model ofEvapotranspiration Fraction (EF) for Mixed Pixels. Biogeosciences (European Geosciences Union). 1 indexed citations
14.
McNair, Christopher, Kexin Xu, Amy C. Mandigo, et al.. (2017). Differential impact of RB status on E2F1 reprogramming in human cancer. Journal of Clinical Investigation. 128(1). 341–358. 70 indexed citations
15.
Chang, Xiujun, et al.. (2016). The clinical significance of loss of FHIT and PTEN expression in 289 patients with non-small-cell lung cancer. Translational Cancer Research. 5(3). 294–301. 3 indexed citations
16.
Zhou, Ti, et al.. (2016). Remote sensing research of evapotranspiration over heterogeneous surfaces: A review. National Remote Sensing Bulletin. 20(2). 257–277. 1 indexed citations
17.
Pomerantz, Mark M., Fugen Li, David Y. Takeda, et al.. (2015). The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nature Genetics. 47(11). 1346–1351. 266 indexed citations
18.
Yang, Lei, Tianhui Zhang, Ming Han, et al.. (2014). Analysis of the surgical treatment of endobronchial tuberculosis (EBTB). Surgery Today. 44(8). 1434–1437. 8 indexed citations
20.
Li, Fugen, et al.. (1997). Generation of cystatin cDNA probe of rainbow trout(Oncorhynchus mykiss)using mixed primer PCR with highly degenerate codons corresponding to conserved amino acid sequences. 5(1). 27–30. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026